Medibios has the technical know how of over 300 formulations across 30 therapeutic categories comprising of new as well as conventional molecules. At present, our R&D activities are focused on process development, which is achieved by sophisticated laboratory, manned by a talented, well-qualified team of professionals, who work on the various dosage forms and formulations. Some of these Formulations have been approved by Pfizer, Abbot for many markets.